|Número de publicación||US7892819 B2|
|Tipo de publicación||Concesión|
|Número de solicitud||US 10/639,186|
|Fecha de publicación||22 Feb 2011|
|Fecha de presentación||11 Ago 2003|
|Fecha de prioridad||1 May 1992|
|También publicado como||US5587128, US6660517, US20110020876|
|Número de publicación||10639186, 639186, US 7892819 B2, US 7892819B2, US-B2-7892819, US7892819 B2, US7892819B2|
|Inventores||Peter Wilding, Larry J. Kricka|
|Cesionario original||Trustees Of The University Of Pennsylvania|
|Exportar cita||BiBTeX, EndNote, RefMan|
|Citas de patentes (44), Otras citas (73), Citada por (40), Clasificaciones (73), Eventos legales (1)|
|Enlaces externos: USPTO, Cesión de USPTO, Espacenet|
This application is a continuation of U.S. application Ser. No. 08/745,771 (filed Nov. 8, 1996) now U.S. Pat. No. 6,660,517, which is a division of U.S. application Ser. No. 08/338,728 (filed Nov. 14, 1994), now U.S. Pat. No. 5,587,128, which is a continuation-in-part of U.S. Ser. No. 08/308,1999 (filed Sep. 19, 1994), now U.S. Pat. No. 5,498,392, which is a continuation of U.S. Ser. No. 07/877,662 (filed May 1, 1992), now abandoned. U.S. application Ser. No. 08/338,728 was filed contemporaneously with commonly-owned U.S. Ser. No. 08/338,369, which is a continuation-in-part of U.S. Ser. Nos. 07/877,702 (filed May 1, 1992), now abandoned, 08/196,021 (filed Feb. 14, 1994), now U.S. Pat. No. 5,635,358 and Ser. No. 08/250,100 (filed May 6, 1994), now abandoned. The disclosures of all of the above-mentioned applications are incorporated herein by reference.
This invention relates generally to methods and apparatus for conducting amplification and various analyses of polynucleotides. More particularly, the invention relates to the design and construction of small, typically single-use, modules for use in analyses involving polynucleotide amplification reactions such as the polymerase chain reaction (PCR).
In recent decades, the art has developed a very large number of protocols, test kits, and cartridges for conducting analyses of biological samples for various diagnostic and monitoring purposes. Immunoassays, immunometric assays, agglutination assays and analyses based on polynucleotide amplification assays (such as polymerase chain reaction), or on various ligand-receptor interactions and/or differential migration of species in a complex sample, all have been used to determine the or concentration of various biological compounds or contaminants, or the presence of particular cell types.
Recently, small, disposable devices have been developed for handling biological samples and for conducting certain clinical tests. Shoji et al. reported the use of a miniature blood gas analyzer fabricated on a silicon wafer. Shoji et al., Sensors and Actuators, 15:101-107 (1988). Sato et al. reported a cell fusion technique using micromechanical silicon devices. Sato et al., Sensors and Actuators, A21-A23:948-953 (1990). Ciba Corning Diagnostics Corp. (USA) has manufactured a microprocessor-controlled laser photometer for detecting blood clotting.
Micromachining technology, using, e.g., silicon substrates, has enabled the manufacture of microengineered devices having structural elements with minimal dimensions ranging from tens of microns (the dimensions of biological cells) to nanometers (the dimensions of some biological macromolecules). Angell et al., Scientific American, 248:44-55 (1983). Wise et al., Science, 254:1335-42 (1991); and Kricka et al., J. Int. Fed. Clin. Chem., 6:54-59 (1994). Most experiments involving structures of this size relate to micromechanics, i.e., mechanical motion and flow properties. The potential capability of these structures has not been exploited fully in the life sciences.
Brunette (Exper. Cell Res., 167:203-217 (1986) and 164:11-26 (1986)) studied the behavior of fibroblasts and epithelial cells in grooves in silicon, titanium-coated polymers and the like. McCartney et al. (Cancer Res., 41:3046-3051 (1981)) examined the behavior of tumor cells in grooved plastic substrates. LaCelle (Blood Cells, 12:179-189 (1986)) studied leukocyte and erythrocyte flow in microcapillaries to gain insight into microcirculation. Hung and Weissman reported a study of fluid dynamics in micromachined channels, but did not produce data associated with an analytic device. Hung et al., Med. and Biol-Engineering, 9:237-245 (1971); and Weissman et al., Am. Inst. Chem. Eng. J., 17:25-30 (1971). Columbus et al. utilized a sandwich composed of two orthogonally orientated v-grooved embossed sheets in the control of capillary flow of biological fluids to discrete ion-selective electrodes in an experimental multi-channel test device. Columbus et al., Clin. Chem., 33:1531-1537 (1987). Masuda et al. and Washizu et al. have reported the use of a fluid flow chamber for the manipulation of cells (e.g., cell fusion). Masuda et al., Proceedings IEEE/IAS Meeting, pp. 1549-1553 (1987); and Washizu et al., Proceedings IEEE/IAS Meeting pp. 1735-1740 (1988). Silicon substrates have been used to develop microdevices for pH measurement and biosensors. McConnell et al., Science, 257:1906-12 (1992); and Erickson et al., Clin. Chem., 39:283-7 (1993). However, the potential of using such devices for the analysis of biological fluids heretofore has remained largely unexplored.
Methodologies for using polymerase chain reaction (PCR) to amplify a segment of DNA are well established. (See, e.g., Maniatis et al., Molecular Cloning: A Laboratory Manual, Cold Spring Harbor Laboratory Press, 1989, pp. 14.1-14.35.) A PCR amplification reaction can be performed on a DNA template using a thermostable DNA polymerase, e.g., Taq DNA polymerase (Chien et al. J. Bacterial., 127:1550 (1976)), nucleoside triphosphates, and two oligonucleotides with different sequences, complementary to sequences that lie on opposite strands of the template DNA and which flank the segment of DNA that is to be amplified (“primers”). The reaction components are cycled between a higher temperature (e.g., 94° C.) for dehybridizing (“melting”) double stranded template, DNA, followed by lower temperatures (e.g., 40-60° C. for annealing of primers and, e.g., 70-75° C. for polymerization). A repeated reaction cycle between dehybridization, annealing and polymerization temperatures provides approximately exponential amplification of the template DNA. For example, up to 1 μg of target DNA up to 2 kb in length can be obtained from 30-35 cycles of amplification with only 10−6 μg of starting DNA. Machines for performing automated PCR chain reactions using a thermal cycler are available (Perkin Elmer Corp.)
Polynucleotide amplification has been applied to the diagnosis of genetic disorders (Engelke et al., Proc. Natl. Acad. Sci., 85:544 (1988), the detection of nucleic acid sequences of pathogenic organisms in clinical samples (Ou et al., Science, 239:295 (1988)), the genetic identification of forensic samples, e.g., sperm (Li et al., Nature, 335:414 (1988)), the analysis of mutations in activated oncogenes (Farr et al., Proc. Natl. Acad. Sci., 85:1629 (1988)) and in many aspects of molecular cloning (Oste, BioTechniques, 6:162 (1988)). Polynucleotide amplification assays can be used in a wide range of applications such as the generation of specific sequences of cloned double-stranded DNA for use as probes, the generation of probes specific for uncloned genes by selective amplification of particular segments of cDNA, the generation of libraries of cDNA from small amounts of mRNA, the generation of large amounts of DNA for sequencing, and the analysis of mutations.
A wide variety of devices and systems has been described in the art for conducting polynucleotide amplification reactions using thermal cycling procedures. Templeton, Diag. Mol. Path., 1:58-72 (1993); Lizardi et. al., Biotechnology, 6:1197-1202 (1988); Backman et al., Eur. Patent No. 320308 (1989); and Panaccio et al., BioTechniques, 14:238-43 (1993). The devices use a wide variety of design principles for transfer, such as water baths, air baths and dry blocks such as aluminum. Haff et al., BioTechniques, 10:102-12 (1991); Findlay et al., Clin. Chem., 39:1927-33 (1993); Wittwer et al., Nucl. Acids Res., 17:4353-7 (1989). PCR reactions in small reaction volumes have been described. Wittwer et al., Anal. Biochem., 186:328-31 (1990); and Wittwer et al., Clin. Chem., 39:804-9 (1993). Polynucleotide amplification micro-devices fabricated from silicon also have been described. Northrup et al., in: Digest of Technical Papers: Transducers 1993 (Proc. 7th International Conference on Solid State Sensors and Actuators) Institute of Electrical and Electronic Engineers, New York, N.Y., pp. 924-6; and Northrup et al., PCT WO 94/05414 (1994).
Silica particles have been shown to bind to nucleic acids, and have been used to isolate nucleic acids prior to PCR analysis. Zeillinger et. al., BioTechniques, 14:202-3 (1993). While the art has described the use of silicon and other substrates fabricated with microchannels and chambers for use in a variety of analyses, little attention has been focused on methods for the modification of micromachined silicon or other surfaces, to diminish binding or other properties of the surfaces, which can inhibit reactions, such as polynucleotide amplification reactions, conducted in the devices. Northrup et al. describe the chemical silanization of a PCR reaction chamber in a silicon substrate having a depth of 0.5 mm. Northrup et al., in: Digest of Technical Papers: Transducers 1993 (Proc. 7th International Conference on Solid State Sensors and Actuators) Institute of Electrical and Electronic Engineers, New York, N.Y., pp. 924-6; and Northrup et al., PCT WO 94/05414 (1994). The reference of Northrup et al., (in: Digest of Technical Papers: Transducers 1993), however, discloses that, in the absence of silanization, untreated silicon surfaces of the reaction chambers had no inhibitory effect on the PCR reaction.
There is a need for convenient, rapid systems for polynucleotide amplification analyses, which could be used clinically in a wide range of potential applications in clinical tests such as tests for paternity, and genetic and infectious diseases and a wide variety of other tests in the environmental and life sciences. There is a need for the development of micro-devices fabricated in substrates such as silicon which permit polynucleotide amplification reactions to be conducted in high yields without interfering effects on the reaction caused by the surfaces of the substrate.
An object of the invention is to provide microscale analytical devices with optimal reaction environments for conducting polynucleotide amplification reactions which can be used to detect very low concentrations of a polynucleotide and to produce analytical results rapidly. Another object is to provide easily mass produced, disposable, small (e.g., less than about 1 cc in volume) devices having functional elements capable of rapid, automated polynucleotide amplification analyses of a preselected cell or cell-free sample, in a range of applications. It is a further object of the invention to provide agents for use in microscale reaction chambers fabricated in solid substrates such as silicon, to diminish potential inhibitory effects of the substrate surfaces on a polynucleotide amplification reaction. It is a further object of the invention to provide apparatus for delivering reagents and sample fluids to and from microscale polynucleotide amplification chambers fabricated in solid substrates such as silicon, and to provide apparatus for sealing the reaction chamber during an amplification reaction. It is yet another object of the invention to provide apparatus that can be used to implement a range of rapid clinical tests, e.g., tests for viral or bacterial infection, tests for cell culture contaminants, or tests for the presence of a recombinant DNA or a gene in a cell, and the like.
These and other objects and features of the invention will be apparent from the description, drawings and claims which follow.
The invention provides a family of small, mass produced, typically one-use devices (sometimes referred to herein as “chips”) for conducting a reaction to enable the rapid amplification of a polynucleotide in a sample. In one embodiment, the device comprises a solid substrate that is fabricated to comprise a mesoscale polynucleotide amplification reaction chamber. The device also may include a cover, e.g., a transparent cover, disposed over the substrate, to seal at least a portion of the reaction chamber during an amplification reaction. The device further includes at least one port in fluid communication with the reaction chamber, for introducing a sample into the chamber (sometimes referred to herein as a “sample inlet port” or inlet port“). The device may include one or more flow channels extending from the ports to the reaction chamber, and/or connecting two or more reaction chambers. The device also may include one or more additional ports in fluid communication with the reaction chamber, to serve as access ports, inlet/outlet ports and/or vents. One or more ports and/or flow channels of the device may be fabricated in the cover or in the substrate. In the device, the reaction chamber may be provided with a composition which diminishes inhibition of a polynucleotide amplification reaction by the wall(s) defining the reaction chamber. The device may also include means for thermally cycling the contents of the chamber to permit amplification of a sample polynucleotide.
The term “mesoscale” is used herein with reference to reaction chambers or flow channels, at least one of which has at least one cross-sectional dimension between about 0.1 μm and 1,000 μm. The flow channels leading to the reaction chamber have preferred widths and depths on the order of about 2.0 to 500 μm. Chambers in the substrate wherein amplification takes place may have one or more larger dimensions, e.g., widths and/or lengths of about 1 to 20 mm. Preferred reaction chamber widths and lengths are on the order of about 0.5 to 15 mm. The reaction chambers are fabricated with depths on the order of about 0.1 to at most about 1,000 μm. Typically, the reaction chambers are fabricated with depths less than 500 μm, e.g., less than about 300 μm, and optionally less than about 80 μm. Fabrication of the reaction chamber, with shallow depths, e.g., less than 300 μm, advantageously facilitates heat transfer to the reaction chamber contents, e.g., through the substrate, and permits efficient thermal cycling during an amplification reaction requiring thermal cycling. However, in some embodiments, the reaction chambers may be fabricated with depths between about 500 μm and 1,000 μm. The overall size of the device ranges from microns to a few millimeters in thickness, depending on the material from which it is constructed, and approximately 0.2 to 5.0 centimeters in length or width.
The devices may be used to amplify and/or analyze microvolumes of a sample, introduced into the flow system through an inlet port defined, e.g., by a hole communicating through the substrate or the cover. The volume of the mesoscale flow system typically will be less than 50 μl, and the volume of the reaction chambers is often less than 20 μl, e.g., 10 μl or less. The volume of the individual channels and chambers in another embodiment may be less than 1 μl, e.g., in the nanoliter or picoliter range. Polynucleotides present in very low concentrations, (e.g., nanogram quantities) can be rapidly amplified (e.g., in less than ten minutes) and detected. After a polynucleotide amplification assay is complete, the devices may be discarded or they may be cleaned and re-used.
In one embodiment, reaction chambers may be fabricated wherein the ratio of the surface area of the walls defining the reaction chamber to the volume of the reaction chamber is greater than about 3 mm2/μl. Chambers also may be fabricated with even higher surface area to volume ratios, such as 5 mm2/μl or, optionally, greater than 10 mm2/μl. As the ratio of the surface area to volume increases, heat transfer through the substrate to and from the reaction chamber contents is facilitated, and thus thermal cycling of the reaction becomes more efficient, and the productivity of the reaction is increased. Additionally, however, as the ratio of the surface area to volume increases, potential inhibitory effects of the walls of the substrate on the polynucleotide amplification reaction are increased. Depending on the material from which the device is made, the wall surfaces of the mesoscale channels and chambers could interfere with the polynucleotide amplification, e.g., via binding interactions between the material and sample polynucleotides or amplification reagents.
The invention provides a range of compositions which may be provided in the reaction chamber to diminish the potentially inhibitory effects of the reaction chamber wall surfaces, such as silicon surfaces, on the reaction. The compositions are particularly useful in reaction chambers having a surface area to volume ratio greater than about 3 mm2/μl or 5 mm2/μl, or, in another embodiment, in chambers wherein the ratio exceeds about 10 mm2/μl. The device also may include a cover disposed over the reaction chamber to seal the reaction chamber during an amplification reaction. The cover may comprise a material such as glass or silicon, or a plastic material. The use of a cover disposed over the reaction chamber increases the total amount of surface area in contact with fluid in the reaction chamber. The surface of the cover exposed to the reaction chamber also may be treated with compositions as disclosed herein to reduce potentially inhibitory effects of the cover surface material on the amplication reaction.
A composition provided in the reaction chamber to diminish inhibition of an amplification reaction by a wall of the reaction chamber may be covalently or non-covalently adhered to the surface of the reaction chamber wall, or may be provided in solution in the reaction chamber during an amplification reaction. In one embodiment, the wall surfaces of one or more reaction chamber(s) and/or channel(s) in the device may be coated with a silane, using a silanization reagent such as dimethychlorosilane, dimethydichlorosilane, hexamethyldisilazane or trimethylchlorosilane (available, e.g., from Pierce, Rockford, Ill.). Alternatively, the surface of the walls of the reaction chamber(s) and/or the flow channel(s), e.g., fabricated within a silicon substrate, may be provided with a relatively inert coating, for example, using a siliconizing reagent, such as Aquasil™ or Surfasil™ (Pierce, Rockford, Ill.), or Sigmacote™ (Sigma Chemical Co., St. Louis, Mo.). Siliconizing reagents available from commercial manufacturers, such as Pierce (Rockford, Ill.) or Sigma Chemical Co. (St. Louis, Mo.), are organosilanes containing a hydrolyzable group, which can hydrolyze in solution to form a silanol which can polymerize and form a film over the surface of the chamber, and can react with hydroxyl groups on the surface of the chamber, such that the film is tightly bonded over the entire surface. The coating may further include a macromolecule (sometimes referred to herein as a “blocking agent”) noncovalently or covalently associated with the silicone coating, to further reduce inhibitory effects of the wall of the reaction chamber on the amplification reaction. Useful macromolecules include an amino acid polymer, or polymers such as polyvinylpyrrolidone, polyadenylic acid and polymaleimide.
A silicon oxide film may be provided on the surface of the reaction chamber and/or channel walls, in a silicon substrate, to reduce inhibition of the amplification reaction by the wall surfaces. The silicon oxide film may be formed by a thermal process wherein the silicon substrate is heated in the presence of oxygen. Alternatively, a plasma-enhanced oxidation or plasma-enhanced chemical vapor deposition process may be utilized. Additionally the reaction chamber and/or channel walls may be coated with a relatively inert polymer such as a poly (vinyl chloride).
Prior to addition of the sample polynucleotide and amplification reagents to the reaction chamber, another polynucleotide (sometimes referred to herein as a “blocking” polynucleotide) may be added to the chamber, such as genomic DNA or polyadenylic acid, preferably at a concentration greater than the concentration of the sample polynucleotide. This permits the blocking polynucleotide to occupy any sites on the wall surfaces that could potentially bind to the sample polynucleotide and reduce the yield of the reaction or the precision of the assay. Thus, in one-embodiment, a blocking polynucleotide may be provided in a reaction chamber fabricated within a silicon substrate, such that the blocking polynucleotide may occupy any polynucleotide binding sites, such as free hydroxyl groups, on the wall surfaces of the reaction chamber. To avoid interfering with the amplification reaction, the blocking polynucleotide should comprise sequences unrelated to that of the sample polynucleotide. Other compositions which bind to the chamber wall surfaces, such as polyguanylic acid or various polypeptides such as casein or serum albumin, could also be utilized as a blocking agent.
The devices may be utilized to implement a polynucleotide amplification reaction, such as a polymerase chain reaction (PCR), in the reaction chamber. The reaction chamber may be provided with reagents for PCR including a sample polynucleotide, polymerase, nucleoside triphosphates, a first primer hybridizable with the sample polynucleotide, and a second primer hybridizable with a sequence that is complementary to the sample polynucleotide, wherein the first and second primers define the termini of the amplified polynucleotide product. The device also may include means for thermally cycling the contents of the amplification reaction chamber, such that, in each cycle, e.g., the temperature is controlled to 1) dehybridize (“melt”) double stranded polynucleotide, 2) anneal the primers to single stranded polynucleotide, and 3) synthesize amplified polynucleotide between the primers. Other amplification methods available in the art also may be utilized, including, but not limited to: (1) target polynucleotide amplification methods such as self-sustained sequence replication (3SR) and strand-displacement amplification (SDA); (2) methods based on amplification of a signal attached to the target DNA, such as “branched chain” DNA amplification (Chiron Corp.); (3) methods based on amplification of probe DNA, such as ligase chain reaction (LCR) and QB replicase amplification (QBR); and (4) various other methods such as ligation activated transcription (LAT), nucleic acid sequence-based amplification (NASBA), repair chain reaction (RCR) and cycling probe reaction (CPR) (for a review of these methods, see pp. 2-7 of The Genesis Report, DX, Vol. 3, No. 4, February 1994; Genesis Group, Montclair, N.J.).
The reaction chamber may be fabricated with one section which is thermally cycled sequentially between the required temperatures for polynucleotide amplification reactions requiring thermal cycling, such as conventional PCR. Alternatively, the reaction chamber may comprise two or more sections, set at the different temperatures required for dehybridization, annealing and polymerization, in which case the device further comprises means for transferring the contents of the chamber between the sections to implement the reaction, e.g., a pump controlled by a computer. The reaction chamber may be bound in at least a portion of the chamber by a cover disposed over the substrate. The device may further include means for detecting the amplified polynucleotide, as disclosed herein. The devices may be used to implement a variety of automated, sensitive and rapid polynucleotide analyses, including analyses for the presence of polynucleotides in cells or in solution, or for analyses for a virus or cell types using the presence of a particular polynucleotide as a marker.
The mesoscale flow channel(s) and reaction chamber(s) may be designed and fabricated from solid substrates using established micromachining methods such as photolithography, etching and disposition techniques, laser machining, LIGA processing ('Becker et al., Microelec. Eng. 4: 35-56, 1986) and plastic molding. The mesoscale flow systems in the devices may be constructed by fabricating flow channels and one or more reaction chambers into the surface of the substrate, and then adhering or clamping a cover over the surface. The solid substrate and/or cover may comprise a material such as silicon, polysilicon, silica, glass, gallium arsenide, polyimide, silicon nitride and silicon dioxide. The cover and/or the substrate alternatively may comprise a plastic material such as an acrylic, polycarbonate polystyrene or polyethylene. Optionally the cover and/or substrate may comprise a transparent material.
An appliance also may be provided, for use with the device, which contains a nesting site for holding the substrate of the device and which optionally mates one or more input ports on the substrate with one or more flow lines in the appliance. After a biological fluid sample suspected to contain a particular polynucleotide is applied to the inlet port, the substrate is placed in the appliance and pumps, e.g., disposed in the appliance, are actuated to force the sample through the flow system. Alternatively, a sample may be injected into the substrate by the appliance (e.g. by a syringe fitted to the appliance). Reagents required for the assay, such as a polymerase enzyme, may be added (in liquid or in dry form) to the polynucleotide sample prior to injection into the substrate. Alternatively, reagents necessary to complete the assay can be injected into the reaction chamber from a separate inlet port, e.g., by the appliance. Fluid samples and reagents may also enter the mesoscale flow system by capillary action or by gravity.
The invention also provides means for sealing one or more of the fluid inlet/outlet ports in the device during an amplification reaction. This advantageously prevents evaporation of liquids during thermal cycling and thus maintains the preferred reaction concentrations during the amplification reaction. In one embodiment, an apparatus including means for delivering fluid to and from the reaction chamber through a port in the device, and adapted to interfit and/or interlock with the port is provided, which'can reversibly seal the port after delivery of fluid to the reaction chamber. For example, the fluid delivery apparatus may comprise a syringe or pipette. In one embodiment, the fluid delivery apparatus may comprise a pipette including a pipette tip provided with an aperture for transferring fluid between the pipette and the port. The pipette tip optionally may be releasable from the pipette, and may be disposable to prevent contamination between samples.
The device may include a substrate comprising a heat conducting material such as silicon, as well as a cover disposed over the substrate, which may comprise a transparent material such as glass or a plastic. The device also includes the mesoscale polynucleotide amplification chamber, fabricated within the substrate or the cover. The cover may include a cavity for receiving and interfitting with the pipette used to deliver sample and reagent solutions to and from the reaction chamber. The device may further include a flow channel that communicates through the substrate and/or the cover between the aperture of the pipette tip and the reaction chamber, when the pipette is fitted within the cavity. The aperture may be positioned on a wall of the pipette tip to permit the pipette tip to move between a first position which permits transfer of fluid from the tip through the aperture and the channel to the reaction chamber, and a second position to permit the aperture to face a wall of the cavity, thereby to seal the flow channel and the reaction chamber during a reaction. Additionally, a depressible member may be provided which extends from the substrate and can seal the port upon depression of the member against the port.
The temperature of one or more section(s) in the reaction chamber can be regulated by, e.g., providing one or more electrical resistance heaters in the substrate near the reaction chamber, or by using a pulsed laser or other source of electromagnetic energy directed to the reaction chamber. The appliance may include electrical contacts in the nesting region which mate with contacts integrated into the structure of the substrate, e.g., to power electrical resistance heating of the reaction chamber. A cooling element may also be provided in the appliance, to assist in the thermal regulation of the reaction chamber. The appliance may be provided with conventional circuitry in communication with sensors in the device for thermally regulating the temperature cycles required for the dehybridization and polymerization reactions.
The amplified polynucleotide produced by the polynucleotide amplification reaction in the mesoscale reaction chamber can be collected through a port in the substrate and detected. Alternatively, specific reagents and methods known in the art may be employed to directly detect amplification products in the reaction chamber (“Taq Man”™ PCR reagents and kit, available from Perkin Elmer Corp., for example). As another alternative, a mesoscale detection region may be microfabricated in the substrate, in fluid communication with the reaction chamber in the device, as a part of the mesoscale flow system. The detection region may include a labeled binding moiety, such as a labeled polynucleotide or antibody probe, capable of detectably binding with the amplified polynucleotide. The presence of polymerized polynucleotide product in the detection region can be detected, e.g., by optical detection of agglutination of the polymerized polynucleotide and the binding moiety through a glass cover over the detection region or through a translucent or transparent section of the substrate itself. Alternatively, the detection region may comprise a series of channels or microlithographic arrays for electrophoretically separating and detecting an amplified polynucleotide.
A positive assay may also be indicated by detectable changes in sample fluid flow properties, such as changes in pressure or electrical conductivity at different points in the flow system upon production of amplified polynucleotide in the reaction chamber. In one embodiment, the device comprises a mesoscale flow system which includes a polynucleotide amplification reaction chamber, and a detection region (e.g., a chamber or a portion of a flow channel), used in combination with an appliance which includes sensing equipment such as a spectrophotometer capable of reading a positive result through an optical window, e.g., disposed over the detection region. The appliance may also be designed to receive electrical signals indicative of a pressure reading, conductivity, or the like, sensed in the reaction chamber, the detection region, or some other region of the flow system.
The substrate may comprise a plurality of reaction and/or detection chambers to enable the rapid parallel amplification and/or detection of several polynucleotides in a mixture. The mesoscale flow system may include protrusions, or a section of reduced cross-sectional area, to cause lysis of cells in the microsample prior to delivery to the reaction chamber. Sharp edged pieces of silicon, trapped in the flow path, can be used as a lysis means. The mesoscale flow system also may include a cell capture region comprising a binding moiety, e.g., immobilized on a wall of a flow channel, which binds a particular type of cell in a heterogeneous cell population at a relatively low fluid flow rate, and at a greater flow rate or by changing the nature of the solvent, for example, releases the cell type prior to delivery of the cells to a cell lysis region, then to a reaction chamber. In this embodiment, intracellular DNA or RNA is isolated from a selected cell subpopulation and delivered to the mesoscale reaction chamber for polynucleotide analysis in one device. In an alternative embodiment, the binding reagent may by immobilized on a solid particle, such as a latex or magnetic bead, as described below.
Complex-forming agents, such as magnetic beads coated with a polynucleotide probe, may be provided within the mesoscale flow system, which can be moved along the flow system by an external magnetic field, e.g., in the appliance. The polynucleotide probe immobilized on the magnetic beads enables the beads to bind to amplified polynucleotide in the reaction chamber or in a separate detection chamber. Magnetic beads containing an immobilized polynucleotide probe may be, e.g., carried through the flow system or otherwise introduced to the reaction chamber at the end of an assay to bind to the amplified polynucleotide product. The bound polynucleotide may then be transported on the magnetic beads to a detection or purification chamber in the flow system, or to a collection port. Alternatively, the magnetic beads may be held in place at a predetermined location in the device, then transported to a detection or purification chamber after binding the polynucleotide product.
Some of the features and benefits of the devices are illustrated in Table 1. The devices can provide a rapid test for the detection of pathogenic bacteria or viruses, or for the presence of certain cell types, or the presence of a gene or a recombinant DNA sequence in a cell. The devices as disclosed herein are all characterized by a mesoscale flow system including a polynucleotide amplification reaction chamber, preferably having at least one mesocale dimension, which is used to amplify a polynucleotide in a sample, and which may be provided with the required amplification reagents. The device may be used to amplify a polynucleotide in a wide range of applications. At the conclusion of the assay the device may be discarded, or it may be cleaned and re-used.
No limits to the number of device
designs or applications available.
Allows reliable, standardized,
mass production of devices.
Allows competitive pricing with
Disposable nature for single-use
No bulky instrumentation
required. Lends itself to
portable units and systems
designed for use in non-
environments. Minimal storage
and shipping costs.
Minimal sample and reagent
volumes required. Reduces
reagent costs, especially for
more expensive, specialized test
procedures. Allows simplified
Devices can be sterilized for use
in microbiological assays and
other procedures requiring clean
Minimizes biohazards. Ensures
Can perform multiple processes or
analyses on a single device.
Allows panel assays.
Expands capabilities for assay
process monitoring to virtually
any system. Allows broad range
Reduces per process cost to the
user for certain applications.
Like reference characters in the respective drawn figures indicate corresponding parts. The drawings are not necessarily to scale.
The invention provides a family of small, mass produced, typically one-use devices for performing polynucleotide amplification reactions to enable the rapid amplification of polynucleotides in fluid samples. The device comprises a solid substrate, fabricated to include at least one polynucleotide amplification reaction chamber, and typically is of a length and/or width ranging from approximately 0.1 to 5.0 centimeters: The channels and chambers in cross-section through the thickness of the device may be triangular, truncated conical, square, rectangular, circular, or any other shape. The device also includes a sample inlet port in fluid communication with the reaction chamber. The device also may include additional ports (which may function as access or inlet/outlet ports, or as vents) disposed at any location over the flow system, and one or more sample flow channels, in fluid communication with the reaction chamber. One or more of the port(s) may be open to the atmosphere or attached to appropriate pressure or suction devices, e.g. for filling or evacuating the device, or they may be sealed, e.g. during an amplification reaction. The port(s) and channel(s) may be fabricated in the substrate or, alternatively, in a cover disposed over the substrate, or both. The device may further include a system for thermally cycling the contents of the reaction chamber to permit amplification of a sample polynucleotide.
At least one of the reaction chambers and the flow channels of the device, and preferably both, have a mesoscale dimension, i.e., at least one cross-sectional dimension on the order of 0.1 to 1,000 μm. The preferred depth of the reaction chamber is less than about 500 μm, more preferably less than 300 μm and most preferably less than 80 μm. The reaction chambers may have larger widths and lengths, e.g., on the order of about 1-20 mm, preferably about 5-15 mm.
The shallow depth of the reaction chamber advantageously facilitates heat transfer to the reaction chamber contents, e.g., from a heater positioned near the substrate, and permits efficient thermal cycling during an amplification reaction. In one embodiment, the reaction chamber may be fabricated such that the ratio of the surface area of the walls of the reaction chamber to the volume of the reaction chamber range from about 3 mm2/μl to greater than about 10 mm2/μl. As the ratio of the surface area to volume increases, heat transfer through the substrate and the effectiveness of the thermal cycling of the reaction is improved. However, potential inhibitory effects of the walls of the substrate on the amplification reaction also maybe increased, depending on the material from which the substrate is constructed. Accordingly, compositions are provided which are useful in diminishing inhibitory effects of wall surfaces, such as silicon surfaces, in reaction chambers in which such treatment is warranted.
Compositions provided to diminish inhibition of an amplification reaction by a wall of the reaction chamber may be covalently or non-covalently adhered on the chamber surface. Alternatively, a composition may be provided in solution in the reaction chamber during an amplification reaction. In one embodiment, the mesoscale flow channel(s) and reaction chambers may be fabricated in a silicon substrate. The walls of the reaction chamber(s) and/or channel(s) then may be coated with a composition which reduces inhibition of the reaction by the silicon surfaces in the device. For example, the silicon surfaces of the device may be coated with any of a range of silanizing reagents available in the art as disclosed herein.
In one embodiment, the devices of the invention may be utilized to conduct a polymerase chain reaction (PCR) in the reaction chamber. The chamber is provided with reagents required for a polymerase chain reaction including the sample polynucleotide, a polymerase such as Taq polymerase, nucleoside triphosphates, a first primer hybridizable with the sample polynucleotide, and a second primer hybridizable with a sequence complementary to the polynucleotide, wherein the first and second primers define the termini of the polymerized product polynucleotide. Reagents may be added to a sample and then delivered through an inlet port to the mesoscale reaction chamber, or the reagents may be delivered to the reaction chamber independently of the sample through a separate inlet port.
The polymerase chain reaction may be performed, according to methods established in the art (Maniatis et al., Molecular Cloning: A Laboratory Manual, Cold Spring Harbor Laboratory Press, 1989). Any thermostable polynucleotide polymerase available in the art may be utilized. The device may include means for thermally cycling the contents of the chamber such that, in each cycle, temperature is controlled to dehybridize double stranded polynucleotide to produce single stranded polynucleotide, and then to anneal the primers and enable polynucleotide polymerization.
Although polynucleotide amplification by the polymerase chain reaction has been described and exemplified herein, it will be appreciated by persons skilled in the art that the devices and methods of the present invention may be utilized equally effectively for a variety of other polynucleotide amplification reactions. Such additional reactions may be thermally dependent, such as the polymerase chain reaction, or they may be carried out at a single temperature (e.g., nucleic acid sequenced-based amplification (NASBA)). Moreover, such reactions may employ a wide variety of amplification reagents and enzymes, including DNA ligase, T7 RNA polymerase and/or reverse transcriptase, among others. Additionally, denaturation of polynucleotides can be accomplished by known chemical or physical methods, alone or combined with temperature change. Polynucleotide amplification reactions that may be practiced in the device of the invention include, but are not limited to: (1) target polynucleotide amplification methods such as self-sustained sequence replication (3SR) and strand-displacement amplification (SDA); (2) methods based on amplification of a signal attached to the target polynucleotide, such as “branched chain” DNA amplification (Chiron Corp. Emeryville, Calif.); (3) methods based on amplification of probe DNA, such as ligase chain reaction (LCR) and QB replicase amplification (QBR); (4) transcription-based methods, such as ligation activated transcription (LAT) and nucleic acid sequence-based amplification (NASBA); and (5) various other amplification methods, such as repair chain reaction (RCR) and cycling probe reaction (CPR) (for a summary of these methods and their commercial sources, see pp. 2-7 of The Genesis Report, DX, Vol. 3, No. 4, February 1994; Genesis Group, Montclair, N.J.).
The capacity of the devices of the invention is small, enabling assays to be performed on very small amounts of a liquid sample (e.g., less than 50 μl and preferably less that 10 μl). The mesoscale flow systems of the devices may be microfabricated with microliter volumes, or alternatively nanoliter volumes or less, which advantageously limits the amount of sample and/or reagent fluids required for an assay. The devices may be used to implement a variety of automated, sensitive and rapid polynucleotide analyses including the analysis of polynucleotides in cells or in solution. At the conclusion of the assay the devices may be cleaned and re-used, or discarded. The use of disposable devices eliminates contamination and reduces biohazards. The sample and reaction mixture at all times can remain entombed, and the low volume simplifies waste disposal.
Analytical devices comprising a solid substrate and optionally, a cover disposed over the substrate, can be designed and fabricated with mesoscale flow channels and reaction chambers from a wide range of materials. The devices optionally may be fabricated from a material which can be sterilized easily. Silicon provides a useful material because of the well-developed technology permitting its precise and efficient fabrication, but a wide range of other materials may be used within the scope of the invention. Other materials which may be utilized include, e.g., gallium arsenide, indium phosphide, aluminum, polysilicon, silicon nitride, silicon dioxide, polyimide and thermocouple materials such as chrome/aluminum, as well as quartz, glass, diamond, polycarbonate, polystyrene and other polymers such as polytetrafluoroethylenes. Other possible materials include superalloys, zircaloy, steel, gold, silver, copper, tungsten, molybdenum, tantalum, KOVAR, ceramics, KEVLAR, KAPTON, MYLAR, brass, sapphire, or any of a range of plastics and organic polymeric materials available in the art.
The port(s), mesoscale flow system, including sample flow channel(s) and reaction chamber(s), and other functional elements may be fabricated inexpensively in large quantities from, e.g., a silicon substrate by any of a variety of micromachining methods known to those skilled in the art, Micromachining methods available include film deposition processes such as chemical vapor deposition, laser-based fabrication or photolithographic techniques such as UV, X-ray, LIGA processes and plastic molding, or etching methods which may be performed by either wet chemical processes or plasma processes. (See, e.g., Manz et al., Trends in Analytical Chemistry, 10:144-149 (1991)). The arrangement of channels, chambers, and multiple ports facilitates the sequential, properly timed, and volumetrically correct addition of sample and reagents within the device.
In one embodiment, flow channels or chambers of varying widths and depths can be fabricated, with at least one having a mesoscale dimension, in a substrate such as silicon. The substrate containing a fabricated mesoscale flow channel and reaction chamber may be covered and sealed with a glass cover clamped, anodically bonded or otherwise adhered to the substrate. Other clear or opaque cover materials may be used. Alternatively, two substrates can be sandwiched, or a substrate can be sandwiched between two glass covers. The use of a transparent cover results in a window which facilitates dynamic viewing of contents in the mesoscale flow system. Other fabrication approaches may be used.
A composition may be provided in the mesoscale amplification reaction chamber or flow channel to passivate the wall surfaces, i.e., to diminish inhibition of the amplification reaction by the wall surfaces if the nature of the wall material necessitates such treatment. The composition may be adhered to the surface of the reaction chamber or channel walls, either covalently or non-covalently. For example, the wall surfaces may be coated with any of a range of silanization agents known in the art. Alternatively, the composition may be provided in the chamber in solution, together with the sample polynucleotide and the amplification reagent during an analysis. Mesoscale reaction chambers may be fabricated wherein the ratio of the surface area of the wall defining the reaction chamber to the volume of the chamber ranges from about 3 mm2/μl to greater than 10 mm2/μl, or, optionally, greater than 20 mm2/μl. As the surface area to volume ratio increases, heat transfer to the reaction chamber through the substrate is improved, and a thermally dependent amplification reaction may be cycled more rapidly. Concurrently, however, inhibitory effect of the wall surfaces may also be enhanced as the ratio of surface area to volume increases. The compositions for reducing inhibition of the amplication reaction by a wall of the reaction chamber are particularly useful in chambers with a high surface area to volume ratio, e.g., greater than about 3 mm2/μl.
It will be appreciated by those skilled in the art that the passivation compositions and methods described herein are applicable to only certain materials wherein it has been observed that amplification reactions may be improved by passivating reaction chamber surfaces. Some materials contemplated for use in devices of the invention are naturally inert, and so would not benefit from the passivation treatments described herein.
The substrate may comprise a heat conductive material such as silicon or glass. The reaction chamber and/or channel walls may be passivated by coating the surface with a silane using a silanization agent available in the art. Useful silanization agents include dimethylchlorosilane (DMCS), dimethyldichlorosilane (DMDCS), hexamethyldisilazane (HMDS), and trimethylchlorosilane (TMCS). These chlorosilanes can react covalently with surface hydroxyl groups on the walls comprising silicon or another material that potentially could interfere with the reaction by, e.g, binding to the sample polynucleotide or the amplification reagents.
Additionally, the walls of the reaction chambers and/or channels may be provided with a silicone coating using a commercially available siliconizing reagent, such as Aquasil™ or Surfasil™ (Pierce, Rockford, Ill.), or Sigmacote™ (Sigma Chemical Co., St. Louis, Mo.). Siliconizing reagents available from commercial manufacturers, such as Pierce (Rockford, Ill.) or Sigma Chemical Co. (St. Louis, Mo.), are organosilanes containing a hydrolyzable group, which can hydrolyze in solution to from a silanol which can polymerize and form a film over the surface of the chamber, and can react with hydroxyl groups on the surface of the chamber, such that the film is tightly bonded over the entire surface of the chamber.
The coating may further include a macromolecule noncovalently or covalently associated with the coating, to further reduce inhibitory effects of the wall of the reaction chamber on the amplification reaction. Useful macromolecules include an amino acid polymer, or polymers such as polyvinylpyrrolidone, polyadenylic acid, or polymaleimide or compositions such as maleimide. Other useful macromolecules include, e.g., poly-L-alanine, poly-L-aspartic acid, polyglycine, poly-L-phenylalanine, or poly-L-tryptophan. A silicon oxide film may be provided on the reaction chamber and/or channel walls to reduce inhibition of the amplification reaction by silicon wall surfaces. The silicon oxide film may be formed by a thermal process wherein the substrate is heated in the presence of oxygen. Alternatively, a plasma-enhanced oxidation or chemical vapor deposition process may be utilized. Additionally, the reaction chamber and/or channel walls may be coated with polymer, such as poly(vinyl chloride). For example, a solution of poly(vinyl chloride) in chloroform may be added to the mesoscale flow system, and then the coating may be formed upon evaporation of the solvent.
In another embodiment, a blocking agent, such as a polynucleotide or polypeptide, may be added to the chamber. For example, genomic DNA or polyadenylic acid may be added to the solution in the reaction chamber, at a concentration preferably greater than the concentration of the sample polynucleotide. This permits the polynucleotide to occupy any sites on the wall surfaces that potentially could bind to the sample polynucleotide or assay reagents andreduce the yield of the reaction. If DNA or RNA is used as the blocking polynucleotide, it should be effectively devoid of sequences that could interfere with the amplification reaction (i.e., it should contain substantially only sequences unrelated to those of the sample polynucleotide). Other compositions which could be utilized as blocking agents include bovine serum albumin or an amino acid polymer, or polymers such as polyvinylpyrrolidone, or polymaleimide or compositions such as maleimide.
A polynucleotide amplification reaction, such as a PCR reaction, may be conducted in the reaction chamber of the device 10 shown in
The appliance 50 may include a heating/cooling element 57 for controlling the temperature within the PCR chamber, e.g., an electrical heating element and/or a refrigeration coil. The electrical heating element may alternatively be integrated into the substrate 10, with contacts for power mated to matching electrical contacts in the appliance below the reaction chamber 22. Alternatively, as shown in
A cooling element, such as a miniature thermoelectric heat pump (Materials Electronic Products Corporation, Trenton, N.J.), Peltier thermocouple or Joule Thompson cooling device, may also be included in the appliance for adjusting the temperature of the reaction chamber. In another embodiment, in the appliance shown in
As illustrated schematically in
In operation, a pump 52 in the appliance is used to deliver the polynucleotide sample and the required reagents from flow line 56 through inlet port 16A to section 22A. The pump 52, which also may be controlled by a microprocessor in the appliance, is then used to transfer the sample periodically, between sections 22A and 22B, through channel 20B to implement a repetitive polynucleotide amplification reaction cycle, while port 16B serves as a vent. When the reaction is complete, the pump 52 in appliance 50 may be used to deliver the sample through port 16B and line 56 in the appliance to port 59 to recover the product. Of course, three or more chambers may be used, each of which is maintained at a temperature suitable for conducting a particular reaction.
In the device 10 shown in
The devices include a solid substrate fabricated with a mesoscale polynucleotide amplification chamber. The devices further include at least one sample inlet port, and a sample flow channel connecting the inlet port to the reaction chamber. One or more ports and flow channels in the device may be fabricated within the substrate (
The invention provides means for sealing one or more of the ports during an amplification reaction, to prevent evaporation of liquids during thermal cycling. In one embodiment, a fluid delivery apparatus is provided for delivering fluid to and from the reaction chamber through the port, which is adapted to interfit with and/or interlock with the port, and which can reversibly seal the port after delivery of fluid to the reaction chamber. A syringe or pipette capable of interfitting with and sealing a fluid entry/exit port in the substrate may be utilized.
As illustrated in
As illustrated in
Devices comprising sealed fluid transfer ports as described above may be utilized for a variety of purposes other than polynucleotide amplification. For example, such ports may be employed in a separate device for sample preparation, immunoassay, or both, as described in commonly owned co-pending Application Serial No. [not yet assigned] the disclosure of which has been incorporated herein by reference.
Amplified polynucleotide present in the reaction chamber may be detected by a range of methods known in the art for detecting polynucleotides, such as electrophoresis in an agarose gel in the presence of ethidium bromide. In one embodiment, the amplified polynucleotide product may be detected directly in the reaction chamber, using commercially available reagents developed for that purpose (e.g., “Taq Man”™ reagents, Perkin Elmer Corporation). The devices also may be provided with a means for detecting amplified polynucleotide disposed either in the substrate or in an appliance used in combination with the substrate. The presence of amplified polynucleotide product in the device can be detected by any of a number of methods including, but not limited to: (1) monitoring the pressure or electrical conductivity of sample fluids entering and/or exiting the reaction chamber in the mesoscale flow system; (2) forming a detectable complex by, e.g., binding the polynucleotide product with a labeled probe, such as a labeled oligonucleotide or antibody probe; and (3) electrophoretically separating the polynucleotide product from reactants and other components of the sample.
The analytical devices also may be utilized in combination with an appliance for viewing the contents of the mesoscale channels in the devices. The appliance in one embodiment may comprise a microscope for viewing the contents of the mesoscale channels in the devices. In another embodiment, a camera may be included in the appliance, as illustrated in the appliance 60 shown schematically in
In one embodiment, the amplified polynucleotide product can be detected by using a detection chamber fabricated in the mesoscale flow system in the substrate in fluid communication with the reaction chamber. The detection chamber is provided with a complex-forming agent e.g., a binding moiety capable of binding to the amplified polynucleotide to form a detectable complex. The binding moiety may comprise, e.g., a polynucleotide or antibody probe. The detection chamber may be fabricated in accordance with methods disclosed in U.S. Ser. No. 07/877,702, filed May 1, 1992, the disclosure of which is incorporated herein by reference. In another embodiment, the complex-forming agent may be added to the reaction chamber after the reaction is complete, to form a detectable complex in that chamber. The device may be used in combination with a detector such as an appliance containing a microprocessor for detecting and recording data obtained during an assay.
In one embodiment, the mesoscale detection chamber may be provided with an inert substrate, e.g., a bead or other particle, capable of binding to the polynucleotide product, to cause detectable agglomeration of the beads in the presence of polymerized polynucleotide product. Particle induced agglomeration can be enhanced by the attachment of a binding moiety, such as an antibody, to the particle.
Antibodies or other binding moieties capable of binding to the polynucleotide product may be introduced into the detection chamber, or may be coated, either chemically or by adsorption, onto the surface of the detection region, or alternatively, onto the surface of an inert particle in the detection region, to induce binding, giving a positive test for the polynucleotide. Techniques for the chemical activation of silaceous surfaces are well developed, particularly in the context of chromatography. (See, e.g., Haller in: Solid Phase Biochemistry, W. H. Scouten, Ed., John Wiley, New York, pp 535-597 (1983); and Mandenius et al., Anal. Biochem. 170: 68-72 (1988)). In one embodiment, the binding moiety may comprise an antibody, and immunoassay techniques known in the art can be performed in the detection region. (See, e.g., Bolton et al., Handbook of Experimental Immunology, Weir D. M., Ed., Blackwell Scientific Publications, Oxford, 1986, Vol. 1, Chapter 26, for a general discussion of immunoassays).
An optically detectable label such as a fluorescent molecule or fluorescent bead may be attached to the binding moiety to enhance detection of the amplified polynucleotide product. Alternatively a second labeled substance, such as a fluorescent labeled antibody may be delivered through the flow system to bind to the bound polynucleotide/binding moiety complex in the detection region to produce a “sandwich” including an optically detectable moiety indicative of the presence of the analyte. The binding of the amplified polynucleotide to the binding moiety in the detection region may be detected, e.g., optically, either visually or by machine, through a transparent window disposed over the detection region. In one embodiment, the production of amplified polynucleotide may be detected by the addition of a dye such as ethidium bromide, which exhibits enhanced fluorescence upon binding to double stranded polynucleotide. Higuchi et al., Biotechnology, 10:413 (1992).
The detection chamber may also be provided with a labeled complementary polynucleotide capable of binding to one of the strands of the amplified polynucleotide, e.g., a labeled polynucleotide immobilized on a bead, to enable the detection of amplified polynucleotide product by means of bead agglutination. Polynucleotide hybridization techniques known in the art may be utilized. Maniatis et al., Molecular Cloning: A Laboratory Manual, 2nd ed., Cold Spring Harbor Press, 1989); Vener et al., Anal. Chem., 198:308-311 (1991). Polynucleotide probes may be attached to, e.g., a submicron latex particle. Wolf et al., Nucleic Acids Research, 15:2911-2926 (1987).
In another embodiment, polynucleotide amplification products may be separated from reactants and other components of the original, sample by electrophoretic methods adaptable to the mesoscale devices of the invention. Such techniques are known in the art. For example, microlithographic arrays have been fabricated in SiO2 for the purpose of electrophoretically separating DNA molecules (Volkmuth & Austin, Nature 358: 600-602, 1992). Additionally, glass chips have been microfabricated with various combinations of channels for performing capillary electrophoresis to separate various biological molecules (Harrison et al., Science 261: 895-897, 1993).
In this embodiment, devices of the invention may be fabricated with a detection region comprising a microlithographic array or series of channels, and electrophoresis may be performed on the chip by providing an appropriate electric field across the region (e.g., by placing microelectrodes at either end of the detection region). The region is provided at one end with a loading area for collecting the contents of the reaction chamber prior to electrophoresis. The various components of the reaction mixture are then separated from one another by electrophoresis. The polynucleotide amplification product may be identified by size comparison with molecules of known size. In one embodiment, size markers are introduced to the detection region (by way of an access port), electrophoretically separated, and the results recorded and stored (e.g. in computer memory). The contents of the reaction chamber are then transferred to the detection region, electrophoretically separated, and the results recorded and compared with the results from electrophoresis of the size markers. In this manner, a polynucleotide amplification product may be identified, as well as being purified for later use, without the use of inert substances and binding moieties for capturing the polynucleotide product.
Polynucleotide amplification also can be detected using a detection region sensitive to flow restriction caused by the presence of polynucleotide produced in the reaction chamber, as is disclosed in U.S. application Ser. No. 08/250,100, the disclosure of which has been incorporated herein by reference. The presence of amplified polynucleotide also may be detected by sensing the pressure or electrical conductivity of the fluid samples entering and exiting the flow system. The conductivity may be measured, e.g., using electrical contacts which extend through the substrate and which mate with electrical contacts in an appliance used in combination with the device. Electrical contacts can be fabricated by known techniques, such as various methods of thermal gradient zone melting. (See Zemel et al., in: Fundamentals and Applications of Chemical Sensors, D. Schuetzle and R. Hammerle, Eds., ACS Symposium Series 309, Washington, D.C., 1986, p. 2.)
Amplified polynucleotide in the reaction chamber can be detected by monitoring the pressure of the sample fluids. For example, in a device 10, nested in appliance 50, illustrated schematically in
Polynucleotide amplification can be detected by the use of a mesoscale flow system sensitive to flow restriction, constructed with a “fractal” pattern, i.e., a pattern of diverging flow channels. The channels may be fabricated on a silicon substrate to have progressively reduced dimensions, providing progressively narrower flow channels. It will be appreciated by those skilled in the art that, although bifurcating channels are exemplified, devices may be fabricated with different numbers of parallel flow channels or other symmetrical or asymmetrical patterns of flow channels with reduced cross-sectional areas. Alternatively, a single channel comprising a narrowed region may be utilized, as described in commonly-owned U.S. application Ser. No. 08/250,100 (incorporated by reference herein).
Flow restriction can be detected, e.g., optically, through a transparent cover over the detection region. Alternatively, one or more pressure sensors may be utilized to detect pressure changes due to changes in fluid properties caused by the accumulation of amplified polynucleotide in or beyond the restricted flow paths. Changes in conductivity upon polynucleotide amplification also may be readily detected through electrical conductivity sensors in contact with the flow region. For example, clogging of the restricted region 40, which blocks flow from inlet port 16A to outlet port 16B, could be detected by a conventional conductivity probe 17 whose output is indicative of the presence or absence of aqueous fluid in the outflow channel. Binding moieties such as labeled antibodies or polynucleotide probes may be included in the restricted flow region, e.g., immobilized, or on a solid phase reactant such as a bead, to bind to the amplified polynucleotide to induce flow reduction restriction in the restricted flow path.
In one embodiment, the mesoscale flow system includes a chamber for lysing cells from a sample in preparation for downstream polynucleotide analysis. The devices also may include a region adapted to separate a particular type of cell in a heterogeneous cell population. The cell separation region includes binding moieties immobilized on structures within the substrate which selectively and reversibly bind a target cell via a characteristic cell surface molecule such as a protein. Other cells in the sample pass downstream and are channelled into a sump or through an exit port. Flow may be continued to wash the cells, e.g., with a flow of buffer. At higher flow rates and pressures, or by changing the solvent composition, the washed cells are released from the structures on which they were immobilized, and thereafter move from the cell separation region downstream to a lysis means, which lyses the cells prior to PCR analysis of intracellular. RNA or DNA.
The cell lysing means typically is disposed in the flow path between the cell separation region (if any) and the polynucleotide amplification reaction chamber to allow the cells to be lysed prior to analysis for an intracellular polynucleotide. As illustrated in
Reagents may be added to the reaction chamber from a separate inlet port in the substrate in fluid communication with the reaction chamber. A filter, microfabricated in the flow channel on the substrate, can be used to filter cell debris prior to polynucleotide analysis. In one embodiment, shown in
In another embodiment, paramagnetic or ferromagnetic beads may be provided within the mesoscale flow system, which can be moved along the flow system by an external magnetic field, e.g., in the appliance. The beads may be used to transport reagents between functional elements in the device, or to displace a sample, a reagent or a reaction mixture. In one embodiment, a polynucleotide probe may be immobilized on the magnetic beads enabling the beads to bind to amplified polynucleotide. Magnetic beads comprising a″ coating of polynucleotide probe may be transported through the flow system to the reaction chamber at the end of an assay to bind to the amplified polynucleotide product. The bound amplified polynucleotide then may be transported on the magnetic beads to a detection or purification chamber in the flow system, or to a collection port.
One embodiment of the invention, illustrated in
The flow channels of device 10 are fitted with filters 24A, 24B and 24C. Filter 24A is designed to prevent cellular debris and other unwanted particulate matter in the sample from entering the reaction chambers. Filters 24B and 24C are included for the purpose of restraining the complex-forming agent (i.e. beads 92) within detection chamber 22C. Accordingly, filters 24A, 24B and 24C need not be identical.
In operation, for a thermally dependent amplification reaction such as PCR, initially, with the channels and chambers full of buffer, port 16A and 16C are open while 16B and 16D are closed. A pump 52 in the appliance delivers the sample fluid and/or reagents required for amplification, such as Taq polymerase, primers and nucleoside triphosphates, via port 16A, through filter 24A, to reaction chamber section 22A. Port 16A next is closed and 16B is opened, and the pump 52 in the appliance is used to reciprocate fluid flow in cycles through flow channel 20B between section 22A, where polynucleotide dehybridization occurs, and section 22B, where annealing and polymerization occur. Port 16C can be used to vent the system, and also optionally to deliver Taq polymerase, nucleoside triphosphates, primers, and other reagents. When the amplification cycling reaction is terminated, e.g., after 30-35 cycles, port 16C is closed, port 16D is opened, and the pump in the appliance is actuated to deliver the reaction products from reaction chamber sections 22A and 22B to detection chamber 22C, which contains, e.g., a polynucleotide complementary to the amplified sense and/or antisense strand, immobilized on beads 92. Amplification product is detected by observing the agglutination of beads 92, e.g., visually through a″ transparent cover disposed over the detection region.
Another embodiment is illustrated in
Another embodiment is illustrated in
In operation, the appliance is used to deliver a sample containing polymerase and other reagents required for reactions such as PCR through inlet port 16A to reaction chamber 22A. Ports 16A and 16D are then closed using a valve connected in the appliance. The heating element in the appliance is then utilized to thermally cycle the reaction chamber between a temperature suitable for dehybridization and temperatures suitable for annealing and polymerization. When the amplification cycles are terminated, ports 16B and 16D are opened and the sample is delivered to detection chamber 22B which contains a polynucleotide probe, e.g., immobilized upon beads 92 or another solid substrate. A positive assay for the polynucleotide is indicated by agglutination of the solid substrate (e.g., beads) in the detection chamber. In the embodiment shown in
The invention will be understood further from the following, nonlimiting examples.
A polymerase chain reaction is performed in the device illustrated schematically in
After the polymerase chain reaction is complete, ports 16B and 16D are opened, and the pump in the appliance connected to port 168 used to deliver the sample from the PCR reaction chamber 22A through flow channel 20B to the detection chamber 228. Detection chamber 22B contains beads 92 comprising a surface immobilized complementary polynucleotide capable of binding the amplified polynucleotide. The agglutination of the beads caused by hybridization reaction between the amplified polynucleotide and the complementary polynucleotide is observed through a window disposed over the detection region 228, and provides a test for the presence of amplified polynucleotide product.
Initially, the valves in the appliance are used to close ports 16C and 16D, while ports 16A and 16B are open. A sample containing a mixture of cells is directed to the sample inlet port 16A by the pump 52 in the appliance, and flows through the mesoscale flow path 20 to separation chamber 22A. Chamber 22A contains binding moieties immobilized on the wall of the chamber which selectively bind to a surface molecule on a desired type of cell in the sample. Remaining cellular components exit the substrate via port 16B. After binding of the desired cell population in chamber 22A, flow with buffer is continued, to wash and assure isolation of the cell population. Next part 16B is closed and 16C is opened. Flow is then increased sufficiently to dislodge the immobilized cells. Flow is continued, forcing cells through membrane piercing protrusions 90 in chamber 22B, which tear open the cells releasing intracellular material.
Sample flow continues past filter 24, which filters off large cellular membrane components and other debris, to mesoscale PCR chamber section 22C, which is connected to PCR chamber section 22D by flow channel 20B. Taq polymerase, primers and other reagents required for the PCR assay next are added to section 22D through port 16B from a mated port and flow path in the appliance, permitting mixing of the intracellular soluble components from the separated subpopulation of cells and the PCR reagents. With port 16A closed, a pump in the appliance connected via port 16B is used to cycle the PCR sample and reagents through flow channel 20B between sections 22C and 22D, set at, e.g., 94° C. and 65° C. respectively, to implement plural polynucleotide melting, annealing and polymerization cycles, enabling the amplification of product polynucleotide. Alternatively, all ports may be closed during the amplification reaction and thermal cycling may be performed as described in Example 1 above. The valves in the appliance next are used to open port 16D. The pump in the appliance connected to port 16B is then used to direct the amplified polynucleotide isolated from the cell population to a detection region comprised of a bifurcating series of flow paths 40. Flow restriction in the detection region 40 serves as a positive indicator of the presence of amplified polynucleotide product and is detected optically through a glass cover disposed over the detection region.
The amplification of a sample polynucleotide, (bacteriophage lambda DNA) in a mesoscale reaction chamber, having dimensions of 80 μm in depth, 8 mm in width and 14 mm in length, fabricated in a silicon substrate and passivated using different passivation methods was examined.
To conduct the reaction, PCR reagents (e.g., nucleotides, AmpliTaq DNA polymerase, primer and the bacteriophage lambda DNA sample) were mixed in tubes and transferred to the mesoscale reaction chamber in the silicon substrate. The final concentrations of the reactants were: nucleotides, 200 mM each, Taq polymerase, 0.25 U/10 ml; primers, 1.0 mM each; DNA template, 0.1 ng per 10 ml. The thermal cycling (normally 35 cycles) was performed automatically using a computer controlled Peltier heater-cooler.
The results of this PCR reaction using different methods of passivation of the walls of the mesoscale reaction chamber fabricated in the silicon substrate are illustrated in
As illustrated in
A mesoscale polynucleotide amplification reaction chamber fabricated in a silicon substrate is provided with a coating to passivate the chamber wall surfaces.
A silicon substrate is provided which is fabricated with fluid inlet and outlet ports and a mesoscale flow system including a flow channel, in fluid communication with the ports, and a polynucleotide amplification reaction chamber. The mesoscale amplification reaction chamber, having dimensions of 80 μm in depth, 8 mm in width, and 14 mm in length, is treated with a siliconizing reagent and optionally a macromolecule to form a coating which passivates the silicon surface. The amplification chamber is filled with a siliconizing reagent such as AquaSil™ or Surfasilml (Pierce, Rockford, Ill. or Sigmacote™ (Sigma Chemical Co., St. Louis, Mo.) using a 100 μl pipette and applying a negative pressure to the exit hole of the chip. The siliconizing reagent is allowed to remain in the chip for at least about 30 min. at room temperature. A constant negative pressure is applied to the exit port to remove the siliconizing reagent, for at least about four hours. About 100 μl of distilled water or 0.1 μl TE buffer is delivered through the flow system via the inlet port to the amplification chamber, using a 100 μl pipette, and a negative pressure is applied to the exit port. The wash is repeated about 6 times. After the last wash, negative pressure is applied to the exit port for about 10 to 15 minutes to drain the channels.
Alternatively, the amplification chamber surface is passivated with a silanization reagent such as dimethyldichlorosilane (DMDCS) or dimethylchlorosilane (DMCS). Methods which can be used for treating surfaces with siliconization or silanization agents are described, e.g., in Pierce, “Instructions: Siliconizing Agents,” Rockford, Ill., 1993, the disclosure of which is incorporated herein by reference.
The amplification reaction chamber then optionally is filled with a solution of a blocking agent comprising macromolecule (about 10 mg/ml of macromolecule in 0.1 M Tris buffer, pH 8.6), e.g., an amino acid polymer (see Table 2), via the inlet port using a 100 μl pipette and applying a negative pressure to the exit port. The macromolecule solution is permitted to remain in the amplification chamber for at least'about 1 hr at 4° C. A negative pressure then is applied to the exit port of the device for about 10 to 15 min. This provides a coating of the macromolecule noncovalently associated with the silicone treated surface.
The effectiveness of different coatings in diminishing the inhibitory effect of silicon on a polynucleotide amplification reaction was tested.
A sample of silicon powder was coated with Surfasil™ (Pierce, Rockford, Ill.) or Sigmacote™ (Sigma Chemical Co., St. Louis, Mo.) and allowed to dry. The silicon particles then were coated with a variety of different macromolecules (obtained from Sigma Chemical Co., St. Louis, Mo.) listed in Table 2, as described in Example 4. About 4 mg of each coated silicon preparation was then placed into separate reaction tubes containing 45 μl of a PCR reaction mixture (see Example 3) and run in a Perkin Elmer Model 9600 thermal cycler.
Additionally, a mesoscale reaction chamber having dimensions of 80 μm in depth, 8 mm in width, and 14 mm in length, was provided with a coating of a silanization reagent or siliconization reagent associated with different macromolecules (Table 2), according to the procedure described in Example 4. A PCR reaction was conducted in the coated reaction chambers using the reagents as described in Example 3. The results using different coatings are shown in Table 2, using a rating scale of 0 to 4, where the positive control (run in the GeneAmp 9600) has a rating of 3. As illustrated in Table 2, the most effective coating was Surfasil™ (Pierce, Rockford, Ill.) in combination with polyvinylpyrrolidone or polyadenylic acid.
on PCR Chip
Sigmacote ™/Poly-L-aspartic acid
Sigmacote ™/Polyadenylic acid
Surfasil ™/Poly-L-aspartic acid
2 to 3
Surfasil ™/Polyadenylic acid
3 to 4
0 to 2
0 to 1
AquaSil ™ in H2O 1:99
It will be understood that the above descriptions are made by way of illustration, and that the invention may take other forms within the spirit of the structures and methods described herein. Variations and modifications will occur to those skilled in the art, and all such variations and modifications are considered to be part of the invention, as defined in the claims.
|Patente citada||Fecha de presentación||Fecha de publicación||Solicitante||Título|
|US3799742||20 Dic 1971||26 Mar 1974||C Coleman||Miniaturized integrated analytical test container|
|US4233029||25 Oct 1978||11 Nov 1980||Eastman Kodak Company||Liquid transport device and method|
|US4302313||10 Mar 1980||24 Nov 1981||Eastman Kodak Company||Electrode-containing device with capillary transport between electrodes|
|US4618476||31 Oct 1984||21 Oct 1986||Eastman Kodak Company||Capillary transport device having speed and meniscus control means|
|US4790640||11 Oct 1985||13 Dic 1988||Nason Frederic L||Laboratory slide|
|US4824247||31 Ago 1987||25 Abr 1989||Avtar Sciences, Inc.||Method and apparatus for measuring sperm penetration|
|US4886761||26 Mar 1987||12 Dic 1989||Yellowstone Diagnostics Corporation||Polysilicon binding assay support and methods|
|US4908112||16 Jun 1988||13 Mar 1990||E. I. Du Pont De Nemours & Co.||Silicon semiconductor wafer for analyzing micronic biological samples|
|US4911782||28 Mar 1988||27 Mar 1990||Cyto-Fluidics, Inc.||Method for forming a miniaturized biological assembly|
|US4963498||15 Ene 1988||16 Oct 1990||Biotrack||Capillary flow device|
|US5135720||30 May 1990||4 Ago 1992||Seiko Instruments Inc.||Reaction chamber for amino-terminal sequence analysis of proteins or peptides|
|US5147606||6 Ago 1990||15 Sep 1992||Miles Inc.||Self-metering fluid analysis device|
|US5176203||31 Jul 1990||5 Ene 1993||Societe De Conseils De Recherches Et D'applications Scientifiques||Apparatus for repeated automatic execution of a thermal cycle for treatment of samples|
|US5188963||17 Nov 1989||23 Feb 1993||Gene Tec Corporation||Device for processing biological specimens for analysis of nucleic acids|
|US5229297 *||15 Oct 1992||20 Jul 1993||Eastman Kodak Company||Containment cuvette for PCR and method of use|
|US5266272 *||31 Oct 1991||30 Nov 1993||Baxter Diagnostics Inc.||Specimen processing and analyzing systems with a station for holding specimen trays during processing|
|US5270183||8 Feb 1991||14 Dic 1993||Beckman Research Institute Of The City Of Hope||Device and method for the automated cycling of solutions between two or more temperatures|
|US5296375||1 May 1992||22 Mar 1994||Trustees Of The University Of Pennsylvania||Mesoscale sperm handling devices|
|US5304487||1 May 1992||19 Abr 1994||Trustees Of The University Of Pennsylvania||Fluid handling in mesoscale analytical devices|
|US5346672||2 Mar 1993||13 Sep 1994||Gene Tec Corporation||Devices for containing biological specimens for thermal processing|
|US5474796||27 May 1993||12 Dic 1995||Protogene Laboratories, Inc.||Method and apparatus for conducting an array of chemical reactions on a support surface|
|US5498392||19 Sep 1994||12 Mar 1996||Trustees Of The University Of Pennsylvania||Mesoscale polynucleotide amplification device and method|
|US5587128||14 Nov 1994||24 Dic 1996||The Trustees Of The University Of Pennsylvania||Mesoscale polynucleotide amplification devices|
|US5632957||9 Sep 1994||27 May 1997||Nanogen||Molecular biological diagnostic systems including electrodes|
|US5639423||31 Ago 1992||17 Jun 1997||The Regents Of The University Of Calfornia||Microfabricated reactor|
|US5955029||12 Mar 1996||21 Sep 1999||Trustees Of The University Of Pennsylvania||Mesoscale polynucleotide amplification device and method|
|US6660517||8 Nov 1996||9 Dic 2003||Trustees Of The University Of Pennsylvania||Mesoscale polynucleotide amplification devices|
|DE3915920A1||16 May 1989||22 Nov 1990||Messerschmitt Boelkow Blohm||Micro-mechanical structures for storing and testing substances - e.g. for disease diagnosis, is made of inert material, e.g. glass, and has defined pattern of depressions, cavities, etc.|
|EP0320308A2||12 Dic 1988||14 Jun 1989||Abbott Laboratories||Method for detecting a target nucleic acid sequence|
|EP0402995A2||7 Jun 1990||19 Dic 1990||Johnson & Johnson Clinical Diagnostics, Inc.||Temperature control device and reaction vessel|
|EP0430248A2||29 Nov 1990||5 Jun 1991||Mochida Pharmaceutical Co., Ltd.||Reaction vessel|
|EP0439182A2||25 Ene 1991||31 Jul 1991||Abbott Laboratories||Improved method of amplifying target nucleic acids applicable to both polymerase and ligase chain reactions|
|EP0483117A2||24 Jul 1986||29 Abr 1992||Boehringer Mannheim Corporation||Capillary flow device|
|EP0611598A2||30 Sep 1993||24 Ago 1994||The Perkin-Elmer Corporation||In situ PCR amplification system|
|EP1318255B1||13 Nov 2002||15 Jul 2009||HUF HÜLSBECK & FÜRST GMBH & CO. KG||Actuation device for a locking device of a door or tail-gate etc. in particular for a vehicle|
|FR2650657A1||Título no disponible|
|GB2191110A||Título no disponible|
|WO1990004645A1||6 Oct 1989||3 May 1990||Molecular Devices Corporation||Methods and apparatus for detecting the effect of cell affecting agents on living cells|
|WO1990009596A1||9 Feb 1990||23 Ago 1990||David Roger Vale||Testing of liquids|
|WO1991013338A2||22 Feb 1991||5 Sep 1991||Hatfield Polytechnic Higher Education Corporation||Biorheological measurement|
|WO1991015750A1||8 Abr 1991||17 Oct 1991||Carri-Med Limited||Microfabricated device for biological cell sorting|
|WO1991016966A1||8 May 1991||14 Nov 1991||Pharmacia Biosensor Ab||Microfluidic structure and process for its manufacture|
|WO1993013220A1||23 Dic 1992||8 Jul 1993||Tepnel Medical Limited||Manipulating nucleic acid sequences|
|WO1994005414A1||31 Ago 1993||17 Mar 1994||The Regents Of The University Of California||Microfabricated reactor|
|1||A. Guyton, et al., Textbook of Medical Physiology, 4th edition, Chapter 8, pp. 98 and 105 (1971).|
|2||Anderson, "Roche Cuts Controversial PCR Fees, Testing Limits," Nature, 355:379 (1992).|
|3||Angell, et al., "Silicon Micromechanical Devices," Scientific American, 248:44-55 (1983).|
|4||Appenzeller et al., "The Man Who Dared to Think Small" and "Engineering a Small World: From Atomic Manipulation to Microfabrication," Science, 254:1300-1342 (1991).|
|5||Backman, "Ligase Chain Reaction: Diagnostic Technoogy for the 1990's and Beyond," Clin. Chem., 38:457-458 (1992).|
|6||Barany, "Genetic Disease Detection and DNA amplification using cloned Thermostable Ligase," Proc. Natl. Acad. Sci., 88:189-193 (1991).|
|7||Biotrack, Ciba Corning, May 1989.|
|8||Brown, "Development of a Stopped-Flow Cytometer," NSF Grant No. ISI 87-60730, (1987).|
|9||Brunette, "Fibroblasts on Micromachined Substrata Orient Hierarchically to Grooves of Different Dimensions," Exper. Cell Res., 164:11-26 (1986).|
|10||Brunette, "Spreading and Orientation of Epithelial Cells on Grooved Substrata," Exper. Cell Res., 167:203-217 (1986).|
|11||Chem. and Eng. News, "Dye Can be Used to Detect Amplified DNA" Apr. 13, 1992, p. 38.|
|12||Chien et al., "Deoxyribonucleic Acid Polymerase from the Extreme Thermophile Thermus Aquaticus," J. Bacteria., 127:1550-1557 (1976).|
|13||Columbus et al., "'Architextured' Fluid Management of Biological Liquids," Clin. Chem., 33:1531-1537 (1987).|
|14||Columbus et al., "‘Architextured’ Fluid Management of Biological Liquids," Clin. Chem., 33:1531-1537 (1987).|
|15||DeLuca, et al., "Coimmobilized Multiemzymes: An in Vitro Model for Cellular Processes," Arch. Biochem. Biophys., 255:285-292 (1983).|
|16||Dessy, "The Microelectronic Chemical Toolbox," Chemometrics and Intelligent Laboratory Systems, 8:311 (1990), Abstract.|
|17||Engelke et al., "Direct Sequencing of Enzymatically Amplified Human Genomic DNA," Proc. Natl. Acad. Sci., 85:544-548 (1988).|
|18||Erlich, ed., "Principles and Applications for DNA Amplification," PCR Technology, Stockton Press, 1989, pp. 32-38.|
|19||Esashi et al., "Integrated Flow Control Systems Fabricated on a Wafer," Proceedings, Electrochemical Society Conference, HI (Oc. 18-23, 1987) Electorchemcal Society, Pennington, N.J., pp. 31-38B, 1987.|
|20||Farr et al., "Analysis of RAS Gene Mutations in Actue Myeloid Leukemia by Polyermase Chain Reaction and Oligonucleotide Probes," Proc. Natl. Acad. Sci., 85:1629-1633 (1988).|
|21||Fromherz et al., "Core-coat conductor of lipid bilayer and micromachined silicon," Biochmica et Biophysica Acta, 1062:103-107 (1991).|
|22||Goin et al., "The 'Intelligent Workstation' for Cell-Surface Phenotyping Based on Principles of Pattern Recognition and Image Analysis," Clin. Chem., 32:1655-1659 (1986).|
|23||Goin et al., "The ‘Intelligent Workstation’ for Cell-Surface Phenotyping Based on Principles of Pattern Recognition and Image Analysis," Clin. Chem., 32:1655-1659 (1986).|
|24||Haller in: Solid Phase Biochemistry, W.H. Scouten, Ed., John Wiley, New York, pp. 535-597 (1983).|
|25||Hanazato et al., "Multi-Enzyme Electrode Using Hyrdrogen-Ion-Sensitive Field-Effect Transistors," IEEE Transactions Electron. Devices; ED 33:47-51 (1986).|
|26||Higuchi et al., "Simultaneous Amplification and Detection of Specific DNA Sequences," Biotechnology, 10:413-417 (1992).|
|27||Hoopman, "Microchanneled Structures," in Microstructures, Sensors and Actuators, Cho et al., Eds., The American Society of Mechanical Engineers, 1990.|
|28||Howe et al., "Resonant-Microbridge Vapor Sensor," IEEE Transactions Electron Devices, ED33:499-506 (1986).|
|29||Hung et al., "Three-Dimensional Uniform in an Oxygenator," Med. & Biol. Engng., 9:237-245 (1971).|
|30||Jonsson et al., "Surface Immobilization Techniques in Combination with Ellipsometry," Methods in Enzymology, 137:381-389 (1988).|
|31||Kawasahi, "Sample Preparation From Blood, Cells; and Other Fluids," in PCR Protocols, Innis et al., eds., Academic Press, Inc., 1990, pp. 146-149.|
|32||Kennedy et al., "Protein-Protein Coupling Reactions and the Applications of Protein Conjugates," Clin. Chem. Acta., 70:1-31 (1976).|
|33||Kenny et al., "Micromachined Silicon Tunnel Sensor For Motion Detection," Appl. Phys. Lett., 58:100-102 (1991).|
|34||Kikuchi et al., "Microchannels Made on Silicon Wafer for Measurement of Flow Properties of Blook Cells," Biorheology, 26:1055 (1989), Abstract.|
|35||Kinosita et al., "Dual-View Microscopy With A Single Camera: Real-Time Imaging of Molecular Orientations And Calcium," J. Cell Biol., 115:67-73 (1991) (Abstract).|
|36||Kittilsland et al., "A Sub-micron Particle Filter in Silicon," Sensors and Actuators, A21-A23:904-907 (1990).|
|37||Kittilsland et al., "Filter Structure for Sub-Micron Filtration Fabricated in Silicon," Journal de Physique, 49(c4):641-644 (1988).|
|38||Kricka et al., "Liquid Transport in Micron and Submicron Channels," SPIE, 1167:159-168 (1989).|
|39||Kricka et al., "Variability in the Adsorption Properties of Microtitre Plates Used as Solid Supports in Enzyme Immunoassay," Clin. Chem., 26:741-744 (1980).|
|40||LaCelle, "Alterations by Leukocytes of Erythrocyte Flow in Microchannels," Blood Cells, 12:179-189 (1986).|
|41||Li et al., "Amplification and Analysis of DNA Sequences in Single Human Sperm and Diploid Cells," Nature, 335:414-417 (1988).|
|42||Mandenius et al., "Coupling of Biomolecules to Silicon Surfaces for Use in Ellipsometry and Other Related Techniques," Methods in Enzymology, 137:388-394 (1988).|
|43||Mandenius et al., "Detection of Biospecific Interactions Using Amplified Ellipsometry," Anal. Biochem., 170:68-72 (1988).|
|44||Mandenius et al., "The Interaction of Proteins and Cells with Affinity Ligands Covelantly Coupled to Silicon Surfaces as Monitored by Elliposmetry," Anal. Biochem., 137:106-114 (1984).|
|45||Manz et al., "Micromachining of Monocrystalline Silicon and Glass for Chemical Analysis Systems," Trends in Anal. Chem., 10:144-149 (1991).|
|46||Masuda et al., "Novel Method of Cell Fusion in Field Constriction Area in Fluid Integrated Circuit," Proc. IEEE/IAS Meeting, pp. 1549-1553 (1987).|
|47||McCartney et al., "Comparison of the Degree of Contact Guidance between Tumor Cells and Normal Cells in Vitro," Cancer Res., 41:3046-3051 (1981).|
|48||Moghissi et al., "A Composite Picture of the Menstural Cycle," Am. J. Obstet. Gynecol., 114:405-418 (1972).|
|49||Nakamura et al., "Immunoassay Method for the Determination of Immunoglobulin G Using Bacterial Magnetic Particles," Anal. Chem., 63:268-272 (1991).|
|50||Nakamura, Immunochemical Assays and Biosensor Technology for the 1990's, American Society of Microbiology, Washington D.C., pp. 205-215 (1992).|
|51||Ontrack(TM), Roche Diagnostic Systems, Sep. 1988.|
|52||Ontrack™, Roche Diagnostic Systems, Sep. 1988.|
|53||Oste, "Polymerase Chain Reaction," Bio Techniques, 6:162-167 (1988).|
|54||Ou et al., "DNA Amplification for Direct Detection of HIV-1 in DNA of Peripheral Blood Monomuclear Cells," Science, 239:295-297 (1988).|
|55||Parce, et al., "Detection of Cell-Affecting Agents with a Silicon Biosensor," Science, 24:243-247 (1989).|
|56||Pfahler et al., "Liquid Transport in Micron and Submicron Channels," Scientific American, 248(4):36-47 (1983).|
|57||Rosenberg et al., "Fc Receptors for IgG on Human Neutrophils: Analysis of Structure and Function by Using Monoclonal Antibody Probes," Clin. Chem., 31:1444-1448 (1985).|
|58||Rosenberg et al., "Immunogold Staining: Adaptation of a Cell-Labeling System for Analysis of Human Leukocyte Subsets," Clin. Chem., 30:1462-1466 (1984).|
|59||Sankolli, et al., "Improvement in the Antibody Binding Characteristics of Microtitre Wells by Pretreatment With Anti-IgG Fc Immunoglobulin," J. Immun. Methods, 104:191-194 (1987).|
|60||Sato, et al., "Individual and Mass Operation of Biological Cells using Micromechanical Silicon Devices," Sensors and Actuators, A21-A23:948-951 (1990).|
|61||Shoji, et al., "Prototype Miniature Blood Gas Analyser Fabricated on a Silicon Wafer," Sensors and Actuators, 15:101-107 (1988).|
|62||Stange et al., "Quantitative Analysis of Immunological Reactions on Silicon Surfaces by Multiple-angle Brewster Angle Reflectometry," Biomaterials, 9:3-6 (1988).|
|63||Van Lintel, "A Piezoelectric Micropump Based on Micromachining of Silicon," Sensors and Acutators, 15:153-167 (1988).|
|64||Vener et al., "A Novel Approach to Nonradioactive Hybridization Assay of Nucleic Acids Using Stained Latex Particles," Anal. Biochem., 198:308-311 (1991).|
|65||Walker et al., "Isothermal in Vitro Amplification of DNA by a Restriction Enzyme/DNA Polymerase System," Proc. Natl. Acad. Sci., 89:392-396 (1992).|
|66||Wallis et al., "Direct-Current Polarization during Field-Assisted Glass-Metal Sealing," J. Amer. Ceramic Soc., 53:563-567 (1970).|
|67||Washizu et al., "Handling of Biological Cells Using Fluid Integrated Circuit," Proceedings IEE/IAS Meeting, pp. 1735-1740 (1988).|
|68||Weissman et al., "Numerical Simulation of Convective Diffusion in Blood Flowing in a Channel with a Steady, Three-Dimensional Velocity Field," Am. Inst. Chem. Eng. J., 17:25-30 (1971).|
|69||Wilding, "New approaches to Point-of-Care Testing," Advanced Hospital Technology Laboratory, Oct. 1990, pp. 38-42.|
|70||Wilding, et al., Clinical Chemistry, 40: 1815-1818 (1994).|
|71||Wolf et al., "Rapid hybridization kinetics of DNA Attached to Submicron Latex Particles," Nucl. Acids Res., 15:2911-2927 (1987).|
|72||Yap, et al., Nucleic Acid Research, 19: 4294 (1991).|
|73||Zemel et al. In: Fundamentals and Applications of Chemical Sensors, D. Schuetzle and R. Hammerle, Eds., Washington, D.C., 1986, p. 2-38.|
|Patente citante||Fecha de presentación||Fecha de publicación||Solicitante||Título|
|US8133671||14 Jul 2008||13 Mar 2012||Handylab, Inc.||Integrated apparatus for performing nucleic acid extraction and diagnostic testing on multiple biological samples|
|US8182763||23 Jul 2008||22 May 2012||Handylab, Inc.||Rack for sample tubes and reagent holders|
|US8216530||14 Oct 2010||10 Jul 2012||Handylab, Inc.||Reagent tube|
|US8287820||17 Sep 2008||16 Oct 2012||Handylab, Inc.||Automated pipetting apparatus having a combined liquid pump and pipette head system|
|US8323900||25 Feb 2011||4 Dic 2012||Handylab, Inc.||Microfluidic system for amplifying and detecting polynucleotides in parallel|
|US8324372||11 Jul 2008||4 Dic 2012||Handylab, Inc.||Polynucleotide capture materials, and methods of using same|
|US8415103||25 Ene 2012||9 Abr 2013||Handylab, Inc.||Microfluidic cartridge|
|US8420015||30 Oct 2007||16 Abr 2013||Handylab, Inc.||Systems and methods for thermal actuation of microfluidic devices|
|US8470586||3 May 2005||25 Jun 2013||Handylab, Inc.||Processing polynucleotide-containing samples|
|US8617905||5 Dic 2011||31 Dic 2013||The Regents Of The University Of Michigan||Thermal microvalves|
|US8679831||9 Feb 2010||25 Mar 2014||Handylab, Inc.||Processing particle-containing samples|
|US8703069||14 Sep 2012||22 Abr 2014||Handylab, Inc.||Moving microdroplets in a microfluidic device|
|US8709787||14 Nov 2007||29 Abr 2014||Handylab, Inc.||Microfluidic cartridge and method of using same|
|US8710211||3 Dic 2012||29 Abr 2014||Handylab, Inc.||Polynucleotide capture materials, and methods of using same|
|US8765076||14 Nov 2007||1 Jul 2014||Handylab, Inc.||Microfluidic valve and method of making same|
|US8852862||16 Nov 2005||7 Oct 2014||Handylab, Inc.||Method for processing polynucleotide-containing samples|
|US8883490||14 Nov 2007||11 Nov 2014||Handylab, Inc.||Fluorescence detector for microfluidic diagnostic system|
|US8894947||19 Mar 2013||25 Nov 2014||Handylab, Inc.||Systems and methods for thermal actuation of microfluidic devices|
|US8961764||14 Oct 2011||24 Feb 2015||Lockheed Martin Corporation||Micro fluidic optic design|
|US9040288||26 Mar 2007||26 May 2015||Handylab, Inc.||Integrated system for processing microfluidic samples, and method of using the same|
|US9051604||23 May 2014||9 Jun 2015||Handylab, Inc.||Heat-reduction methods and systems related to microfluidic devices|
|US9067207||4 Mar 2011||30 Jun 2015||University Of Virginia Patent Foundation||Optical approach for microfluidic DNA electrophoresis detection|
|US9080207||3 Dic 2012||14 Jul 2015||Handylab, Inc.||Microfluidic system for amplifying and detecting polynucleotides in parallel|
|US9186677||14 Jul 2008||17 Nov 2015||Handylab, Inc.||Integrated apparatus for performing nucleic acid extraction and diagnostic testing on multiple biological samples|
|US9217143||25 Abr 2014||22 Dic 2015||Handylab, Inc.||Polynucleotide capture materials, and methods of using same|
|US9222954||27 Mar 2014||29 Dic 2015||Becton, Dickinson And Company||Unitized reagent strip|
|US9238223||5 Abr 2013||19 Ene 2016||Handylab, Inc.||Microfluidic cartridge|
|US9259734||9 Mar 2012||16 Feb 2016||Handylab, Inc.||Integrated apparatus for performing nucleic acid extraction and diagnostic testing on multiple biological samples|
|US9322054||21 Feb 2013||26 Abr 2016||Lockheed Martin Corporation||Microfluidic cartridge|
|US9347586||15 Oct 2012||24 May 2016||Handylab, Inc.||Automated pipetting apparatus having a combined liquid pump and pipette head system|
|US9480983||18 Dic 2015||1 Nov 2016||Becton, Dickinson And Company||Unitized reagent strip|
|US20090155123 *||17 Sep 2008||18 Jun 2009||Handylab, Inc.||Automated Pipetting Apparatus Having a Combined Liquid Pump and Pipette Head System|
|US20110207140 *||25 Feb 2011||25 Ago 2011||Kalyan Handique||Microfluidic system for amplifying and detecting polynucleotides in parallel|
|US20110223605 *||4 Mar 2011||15 Sep 2011||Lockheed Martin Corporation||Multiple-sample microfluidic chip for DNA analysis|
|US20110229897 *||4 Mar 2011||22 Sep 2011||Lockheed Martin Corporation||Optical approach for microfluidic DNA electrophoresis detection|
|US20140000223 *||3 Nov 2011||2 Ene 2014||Boehringer Ingelheim Microparts Gmbh||Method for filling a blister packaging with liquid, and blister packaging with a cavity for filling with liquid|
|USD665095||14 Abr 2011||7 Ago 2012||Handylab, Inc.||Reagent holder|
|USD669191||28 Jul 2010||16 Oct 2012||Handylab, Inc.||Microfluidic cartridge|
|USD692162||30 Sep 2011||22 Oct 2013||Becton, Dickinson And Company||Single piece reagent holder|
|USD742027||21 Oct 2013||27 Oct 2015||Becton, Dickinson And Company||Single piece reagent holder|
|Clasificación de EE.UU.||435/288.5, 435/287.2, 435/288.4, 435/288.6, 435/305.2, 435/305.3, 435/305.1, 435/288.3, 435/288.7, 422/505, 422/504|
|Clasificación internacional||C12M1/34, C12Q1/68, B01D71/02, C12M3/00, B01J19/00, C12M1/26, C12M3/08, C12M1/22, B01D61/18, B01L3/00, B01L7/00, B01D67/00, C40B40/06, B01F5/06, B01L9/00|
|Clasificación cooperativa||Y10T436/25125, Y10S435/81, Y10S435/814, Y10S435/808, Y10S366/03, B01D61/18, B01F5/0601, B01L2300/0864, B01L3/502753, B01L2200/027, B01L7/52, B01L2400/0406, B01L2200/10, B01L2300/1827, C40B40/06, C12M41/46, B01L2300/0867, B01L2300/0816, B01L3/502707, B01D67/0058, B01L3/502715, C12Q1/6844, B01L3/5027, B01D67/0072, B01J2219/00722, B01J2219/0059, C12Q1/686, B01L2400/0487, B01L2200/146, B01D71/02, B01J19/0093, B01L2300/1861, B01L9/527, B01L7/525, B01J19/0046|
|Clasificación europea||B01J19/00R, C12Q1/68D4, B01J19/00C, C12Q1/68D, B01D71/02, B01D61/18, B01L7/525, B01L7/52, B01D67/00M18D, B01L3/5027, B01L3/5027B, B01D67/00M24|